http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-1801331-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04c2e8a5790992b1fe88770ed838608e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-295
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-295
filingDate 1968-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21c3908061543c26b1245bb3f2b7ea8a
publicationDate 1970-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-1801331-A1
titleOfInvention Wisen serine complex and process for its preparation
abstract Fe (III) COMPLEXES WITH D-, L- AND/OR DL-SERINE ARE IRON SOURCES WITH IMPROVED RESORPTION. G3A. And contain Fe and serine in ratio 1 g. atom Fe : 1 mol. serine. Prepared by mixing an aqs. serine salt soln. (pref. serine Na salt soln.) with aqs. FeCl3 soln. in 1:1 molar ratio, filtering the resulting brown soln., then dialysing until the content of Cl- ions corresponds to the content of complexed Fe atoms (Cl:Fe = 1:1), and subsequently lyophilising the soln. (complexes can also be ppted. by adding large amounts of e.g. EtOH, MeOH or Me2CO). Pharmaceutical preparations for oral administration contain the above complexes, which have iron resorption in the GI tract of ca. 70% or more. Additional advantages are the complexes' stability over a pH range of 2-8 (ensuring unchanged passage through the GI tract after oral administration) and, because Fe is in the ferric state, almost unlimited storage stability and low toxicity compared with ferrous-amino acid preparations.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4067994-A
priorityDate 1968-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449527037
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID617
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10129897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71077
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29936
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24380
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450006894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9321
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559465
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451095370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23675763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158610097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410443241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483812

Total number of triples: 40.